Bentham Science Publishers logo

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Click here to see current issues of this journal.

Publisher: Bentham Science Publishers

Related content
Volume 2, Number 6, December 2003

< previous issue | all issues | next issue >

Review article

Cdk5 in the Adult Non-Demented Brain
pp. 375-381(7)
Authors: Fischer A.; Sananbenesi F.; Spiess J.; Radulovic J.

Cannabinoids and Memory; Animal Studies
pp. 389-402(14)
Authors: Castellano C.; Rossi-Arnaud C.; Cestari V.; Costanzi M.

Extracellular ATP and Neurodegeneration
pp. 403-412(10)
Authors: Volonte C.; Amadio S.; Cavaliere F.; D'Ambrosi N.; Vacca F.; Bernardi G.

Stress and Angiotensin II: Novel Therapeutic Opportunities
pp. 413-419(7)
Authors: Armando I.; Seltzer A.; Bregonzio C.; Saavedra J.M.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page